{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:23:51Z","timestamp":1793579031010,"version":"4.5.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Global Antimicrobial Resistance"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.jgar.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T12:49:14Z","timestamp":1542113354000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011\u20132016"],"prefix":"10.1016","volume":"17","author":[{"given":"Michael J.","family":"Dowzicky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Chmela\u0159ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgar.2018.11.007_bib0005","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1517\/14656566.2014.914172","article-title":"Multidrug-resistant and extensively drug-resistant Gram-negative pathogens: current and emerging therapeutic approaches","volume":"15","author":"Karaiskos","year":"2014","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jgar.2018.11.007_bib0010","series-title":"Antimicrobial resistance surveillance in Europe 2016. Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net)","author":"European Centre for Disease Preventionand Control (ECDC)","year":"2017"},{"key":"10.1016\/j.jgar.2018.11.007_bib0015","series-title":"Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics","author":"World Health Organization (WHO)","year":"2017"},{"key":"10.1016\/j.jgar.2018.11.007_bib0020","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ijantimicag.2013.02.022","article-title":"Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004\u20132010","volume":"41","author":"Balode","year":"2013","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jgar.2018.11.007_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000445022","article-title":"Antimicrobial susceptibility among European Gram-negative and Gram-positive isolates collected as part of the Tigecycline Evaluation and Surveillance Trial (2004\u20132014)","volume":"62","author":"Rodloff","year":"2017","journal-title":"Chemotherapy"},{"key":"10.1016\/j.jgar.2018.11.007_bib0030","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standards\u2014tenth edition. CLSI document M07-A10","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2015"},{"key":"10.1016\/j.jgar.2018.11.007_bib0035","series-title":"Breakpoint tables for interpretation of MICs and zone diameters. Version 7.1","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)","year":"2017"},{"key":"10.1016\/j.jgar.2018.11.007_bib0040","series-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2017"},{"key":"10.1016\/j.jgar.2018.11.007_bib0045","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES2013.18.28.20525","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013","volume":"18","author":"Glasner","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2018.11.007_bib0050","doi-asserted-by":"crossref","first-page":"20626","DOI":"10.2807\/1560-7917.ES2013.18.45.20626","article-title":"Czech participants of European antimicrobial resistance surveillance network: carbapenemase-producing Klebsiella pneumoniae in the Czech Republic in 2011","volume":"18","author":"Hrab\u00e1k","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jgar.2018.11.007_bib0055","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1128\/AAC.00107-16","article-title":"Global dissemination of blaKPC into bacterial species beyond Klebsiella pneumoniae and in vitro susceptibility to ceftazidime\u2013avibactam and aztreonam\u2013avibactam","volume":"60","author":"Kazmierczak","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.11.007_bib0060","series-title":"Summary of the latest data on antibiotic consumption in EU","author":"European Centre for Disease Prevention and Control (ECDC)","year":"2016"},{"key":"10.1016\/j.jgar.2018.11.007_bib0065","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1128\/AAC.00881-16","article-title":"Activities of tedizolid and linezolid determined by the reference broth microdilution method against 3,032 Gram-positive bacterial isolates collected in Asia-Pacific, Eastern Europe, and Latin American countries in 2014","volume":"60","author":"Pfaller","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jgar.2018.11.007_bib0070","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkv311","article-title":"In vitro activity of ceftaroline against bacterial pathogens isolated from skin and soft tissue infections in Europe, Russia and Turkey in 2012: results from the Assessing Worldwide Antimicrobial Resistance Evaluation (AWARE) surveillance programme","volume":"71","author":"Karlowsky","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 5","key":"10.1016\/j.jgar.2018.11.007_bib0075","doi-asserted-by":"crossref","first-page":"v2","DOI":"10.1093\/jac\/dky066","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Bulgaria, Romania, Serbia and Croatia","volume":"73","author":"Torumkuney","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 5","key":"10.1016\/j.jgar.2018.11.007_bib0080","doi-asserted-by":"crossref","first-page":"v28","DOI":"10.1093\/jac\/dky069","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in Ukraine and the Slovak Republic","volume":"73","author":"Torumkuney","year":"2018","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl. 5","key":"10.1016\/j.jgar.2018.11.007_bib0085","doi-asserted-by":"crossref","first-page":"v22","DOI":"10.1093\/jac\/dky067","article-title":"Results from the Survey of Antibiotic Resistance (SOAR) 2014-16 in the Czech Republic","volume":"73","author":"Torumkuney","year":"2018","journal-title":"J Antimicrob Chemother"}],"container-title":["Journal of Global Antimicrobial Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213716518302236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T16:46:34Z","timestamp":1560876394000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213716518302236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":17,"alternative-id":["S2213716518302236"],"URL":"https:\/\/doi.org\/10.1016\/j.jgar.2018.11.007","relation":{},"ISSN":["2213-7165"],"issn-type":[{"value":"2213-7165","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from Eastern Europe: Results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2011\u20132016","name":"articletitle","label":"Article Title"},{"value":"Journal of Global Antimicrobial Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgar.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors and Pfizer Inc. Published by Elsevier Ltd. on behalf of International Society for Chemotherapy of Infection and Cancer.","name":"copyright","label":"Copyright"}]}}